Patent ID: 11919964
Assignee: AMGEN INC.
Field: Biotechnology (Chemistry)
Classification: CPC C  A | IPC C

Claim 22:
23. The bispecific heterodimeric antibody of claim 1, wherein:
(a) VL2 comprises the sequence of SEQ ID NO: 28 and VH2 comprises the sequence of SEQ ID NO: 83;
(b) VL2 comprises the sequence of SEQ ID NO: 29 and VH2 comprises the sequence of SEQ ID NO: 84;
(c) VL2 comprises the sequence of SEQ ID NO: 30 and VH2 comprises the sequence of SEQ ID NO: 83;
(d) VL2 comprises the sequence of SEQ ID NO: 31 and VH2 comprises the sequence of SEQ ID NO: 85;
(e) VL2 comprises the sequence of SEQ ID NO: 32 and VH2 comprises the sequence of SEQ ID NO: 86;
(f) VL2 comprises the sequence of SEQ ID NO: 33 and VH2 comprises the sequence of SEQ ID NO: 87;
(g) VL2 comprises the sequence of SEQ ID NO: 34 and VH2 comprises the sequence of SEQ ID NO: 88;
(h) VL2 comprises the sequence of SEQ ID NO: 35 and VH2 comprises the sequence of SEQ ID NO: 89;
(i) VL2 comprises the sequence of SEQ ID NO: 36 and VH2 comprises the sequence of SEQ ID NO: 90;
(j) VL2 comprises the sequence of SEQ ID NO: 37 and VH2 comprises the sequence of SEQ ID NO: 91; or
(k) VL2 comprises the sequence of SEQ ID NO: 38 and VH2 comprises the sequence of SEQ ID NO: 92.